Indeloxazine

This classification denotes an antidepressant agent with the molecular formula C14H17NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 834M09R1KM, chemically known as (r,s)-2-(7-indenyloxymethyl)morpholin but generally known as indeloxazine, which bears US NIH Compound Identifier 3704. European Medicines Agency schedules Indeloxazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08172MIG. The term INDELOXAZINE is an International Non-Proprietary Name. INDELOXAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule indeloxazine under HS 29349990 and SITC 51579. As of Q4 2014, INDELOXAZINE remains the US FDA Preferred Term for this commodity. Indeloxazine bears US NLM identifiers UMLS ID C0063456 and NCI Concept Code C81484. SMILES: O1C(CNCC1)COc1c2CC=Cc2ccc1.